1Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings [ J ]. J Steroid Biochem Mol Biol, 2000, 74 (5) : 357-364.
3Travis RC, Key TJ. Estrogen exposure and breast cancer risk [J]. Breast Cancer Res, 2003, 5(5): 239.
4Pike MC, Spicer DV, Dahmoush L, et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk [J]. Epidemiol Rev, 1993, 15(1): 17.
6Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer [ J]. N Engl J Med, 2006, 354 : 270-282.
7Lupulescu A. Estrogen use and cancer incidence: a review [J]. Cancer Invest, 1995, 13(3) : 287.
8Saundem P, Millar M, Williams K, et al. Expression of estrogen receptor beta( ERbetal ) protein in human breast cancer biopsies [J]. BrJ Cancer, 2002, 86(2): 250.
8Tanner M, Gancberg D, Di L A, et al. Chromogenic in situ hybridization: a practical alternative for flouresence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer sample[J]. Am J Pathol, 2000, 157(5): 1467-1472.
9Meijers H H, Brekelmans C T, Menke P M, et al. Use of genetic test and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation[J]. J Clin Oncol, 2003, 21: 1675-1681.
10Birner P, Oberhuber G, Stani J, et al. Evaluation of the united states food and drug administration-approved scoring and test system of HER-2 protein expression in breast cancer[J]. Clin Cancer Res, 2001, 7(6): 1669-1675.
